SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
456A new use for an old biological. Very cool. (eom)scaram(o)uche-10/15/2003
455Berlex Laboratories Announces Results From Randomized, Placebo-Controlled Study nigel bates-10/14/2003
454MorphoSys / MOR101 and MOR102 (target ICAM-) FRANKFURT -(Dow Jones)- MorphoSys nigel bates-10/9/2003
453Biogen Licenses Oral Psoriasis Therapy From Fumapharm AG Wednesday October 1, 8:software salesperson-10/1/2003
452Roche and Protein Design Labs Restructure Commercial Alliance on Zenapax(R) TuesIcebrg-9/30/2003
451Amazing, what a little immunosuppression can do. Inflammatory disease....... scaram(o)uche-9/26/2003
450This is probably of no relevance to this thread, but here goes anyway. Seems inttom pope-9/25/2003
449Xencor Designs Novel TNF Alpha Inhibitors to Treat Inflammatory Disease Xencor&nigel bates-9/25/2003
448Drugs R D. 2003;4(5):306-309. Cannabis-Based Medicines - GW Pharmaceuticals: Hscaram(o)uche-9/13/2003
447Safety summary, FDA analysis, briefing document for Raptiva. I don't see anscaram(o)uche-9/8/2003
446Fresh from the pipeline Adalimumab Bornadata Bain1 & Melanie Brazil2 1 BornIcebrg-9/1/2003
445Topical PTH (1-34) >>If so, perhaps NPS's version might work too.>Icebrg-8/27/2003
444I assume this is just a topical version of Lilly's Forteo? If so, perhaps NPBiomaven-8/27/2003
443excerpt from today's BioCentury (thanks, RS!)...... MEDI (Gaithersburg, Md.scaram(o)uche-8/4/2003
442Abbott Laboratories and LigoCyte Pharmaceuticals Announce Research Collaborationnigel bates-8/4/2003
441AtheroGenics Reports Results from Phase II Safety and Biomarker Trial of AGIX-42russet-7/16/2003
440Amgen Seeks to Market Drug for Psoriasis From Reuters July 9, 2003 Amgen Isim1-7/9/2003
439Infliximab Not Helpful in Steroid-Refractory Ulcerative Colitis Laurie Barclay,Icebrg-7/4/2003
438Plese, now explain to as why Enbrel does not work in Crohn's while Serano soMiljenko Zuanic-6/28/2003
437[Anti-TNF: novel mechanism of action in Crohn's] >>Published online btuck-6/27/2003
436Sound like short half-life, as expected from dosing. Interesting that they chousMiljenko Zuanic-6/24/2003
435>>Does IMNX (AMGN) has IPR on this molecule/target?<< Yes, but truekeokalani'nui-6/23/2003
434One might have to get the whole article for cMax (If you know dose and volume, btuck-6/23/2003
433Relative high and frequent dose (150 mg TIW), but data are comparable to other aMiljenko Zuanic-6/22/2003
432HUMAX-IL15 Message 19045704Icebrg-6/19/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News